{"filing": {"accession": "0001437749-26-030751", "cik": "0001069530", "ticker": "FLNA", "company_name": "FILANA THERAPEUTICS, INC.", "form_type": "8-K", "filing_type": "8-K", "filing_date": "2026-09-18", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/0001437749-26-030751-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1069530/000143774926030751/0001437749-26-030751-index.htm", "period_of_report": "2026-09-17"}, "html_url": "/api/filings/000143774926030751/stream", "exhibits": [], "sections": [], "tables": [{"table_index": 2, "table_type": "text", "caption": null, "header_text": "\u2610Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)"}, {"table_index": 3, "table_type": "text", "caption": null, "header_text": "Title of each classTradingSymbol(s)Name of each exchange on which registered"}, {"table_index": 5, "table_type": "text", "caption": null, "header_text": "FILANA THERAPEUTICS, INC."}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 25}